«In summary, these encouraging data build upon the real success of our translational efforts in
myeloma over the last decade, and provide exciting new options with the real promise of improving patient outcome,» said Richardson, who is also the R.J. Corman professor at Harvard Medical School.
Not exact matches
Multiple
myeloma, he said, «had been a vague phrase» in his life until he himself was diagnosed with this blood cancer, which strikes just
over 30,000 Americans each year and kills about 12,600.
How one cancer researcher turned his own
myeloma diagnosis into an opportunity, giving others the potential for greater control — and better outcomes —
over their own care.
Analyzing a database of nearly 800 multiple
myeloma patient samples, they discovered that 162 patients with low ADAR1 levels in their tumor cells survived significantly longer
over a three - year period compared to 159 patients with high ADAR1 levels.
With multiple
myeloma, most patients live four to seven years from their date of diagnosis, and most become resistant to chemotherapy drugs
over time.
The research team found
over 200 products of metabolism differed between the healthy volunteers and patients with MGUS or
myeloma, compared to just 26 differences between MGUS patients and
myeloma patients.
About 20 % to 30 % of patients diagnosed with
myeloma will present with renal impairment, and more patients will develop it
over time.
I've gone on a plant based low fat high starch diet and feel great but its always like the sword of Damocles with the possibility of Multiple
Myeloma hanging
over me.